Recombinant Human Hyaluronidase/Trastuzumab Regimen

Preferred Label : Recombinant Human Hyaluronidase/Trastuzumab Regimen;

NCIt synonyms : Trastuzumab Plus Hyaluronidase-oysk Regimen; Hyaluronidase/Trastuzumab Regimen; Hyaluronidase-Trastuzumab Regimen; Hyaluronidase, Recombinant Human/Trastuzumab Regimen; Hyaluronidase-oysk-Trastuzumab Regimen; Trastuzumab/Hyaluronidase-oysk Regimen; Hyaluronidase-oysk/Trastuzumab Regimen; Trastuzumab-Hyaluronidase-oysk Regimen; Herceptin Hylecta Regimen; Trastuzumab and Hyaluronidase-oysk Regimen;

NCIt related terms : Trastuzumab and hyaluronidase monotherapy;

NCIt definition : A regimen consisting of a fixed-dose combination of recombinant human hyaluronidase and trastuzumab that may be used in the treatment of breast cancer.;

NCI Metathesaurus CUI : CL1778892;

Codes from synonyms : 38874;

Details

Origin ID

C186514;

UMLS CUI

C5575304;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Trastuzumab/Hyaluronidase-oysk [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- Single-agent Therapeutic Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients